Avanza Fonder’s IDEAYA Biosciences IDYA Stock Holding History

Avanza Fonder’s Portfolio IDYA Stock Details IDYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-4,344	Closed	-$150K	–	496
2025 Q4	$150K	Buy	+4,344	New	+$138K	﹤0.01%	443

Other funds holding IDYA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Avanza Fonder's IDYA Position: Q1 2026 in Review

Avanza Fonder sold out of IDEAYA Biosciences (IDYA) in Q1 2026, closing a stake of 4,344 shares — an estimated $150K sold.

Avanza Fonder first reported a position in IDYA in Q4 2025 and held it in 1 quarter. The position peaked at $150K in Q4 2025. 253 funds tracked by Wall St. Rank hold IDYA as of Q1 2026.

Avanza Fonder reported no remaining IDEAYA Biosciences position as of Q1 2026 after selling out during the quarter.
Avanza Fonder sold 4,344 IDEAYA Biosciences shares in Q1 2026, an estimated $150K.
Avanza Fonder first reported a position in IDEAYA Biosciences in Q4 2025 and held it in 1 quarter.
Avanza Fonder's IDEAYA Biosciences position peaked at $150K in Q4 2025.
253 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q1 2026.

Based on Avanza Fonder's 13F filing for Q1 2026, filed 15 Apr 2026.